← All companies
NBIX
Neurocrine Biosciences, Inc.
$166.23
-19.27 -10.39%
Key statistics
from XBRL data in SEC filingsMarket cap
$16.9B
Revenue (TTM)
$3.37B
Net income (TTM)
$706M
EPS (TTM)
$6.83
P/E ratio
24.3
Dividend yield
—
Free cash flow
$749M
Cash
$332M
Total assets
$5.36B
Gross margin
—
52-week range
$122.14 – $186.12
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K/A
Jul 31, 2026
10-Q
Quarter ended 2026-06-30
Jul 31, 2026
8-K
Results of operations (earnings release)
Jul 30, 2026
8-K
Director or officer change; Shareholder vote results
May 28, 2026
8-K
Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Regulation FD disclosure
May 18, 2026
10-Q
Quarter ended 2026-03-31
May 5, 2026
8-K
Results of operations (earnings release)
May 5, 2026
8-K
Entered a material agreement
Apr 6, 2026
10-K
Fiscal year ended 2025-12-31
Feb 11, 2026
8-K
Results of operations (earnings release)
Feb 11, 2026
8-K
Director or officer change
Nov 24, 2025
10-Q
Quarter ended 2025-09-30
Oct 28, 2025
8-K
Results of operations (earnings release)
Oct 28, 2025
10-Q
Quarter ended 2025-06-30
Jul 30, 2025
8-K
Results of operations (earnings release)
Jul 30, 2025
8-K
Director or officer change
May 30, 2025
8-K
Director or officer change; Shareholder vote results
May 22, 2025
10-Q
Quarter ended 2025-03-31
May 5, 2025
8-K
Results of operations (earnings release)
May 5, 2025
8-K
Director or officer change; Regulation FD disclosure
Apr 4, 2025
10-K
Fiscal year ended 2024-12-31
Feb 10, 2025
8-K
Results of operations (earnings release)
Feb 6, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Jan 27, 2025
8-K
Other events
Dec 20, 2024
8-K
Other events
Nov 1, 2024
10-Q
Quarter ended 2024-09-30
Oct 30, 2024
8-K
Results of operations (earnings release)
Oct 30, 2024
8-K
Director or officer change
Oct 11, 2024
8-K
Regulation FD disclosure; Other events
Aug 28, 2024
10-Q
Quarter ended 2024-06-30
Aug 1, 2024
8-K
Results of operations (earnings release)
Aug 1, 2024
8-K
Director or officer change; Amended charter or bylaws
May 28, 2024
8-K
Director or officer change; Shareholder vote results
May 23, 2024
10-Q
Quarter ended 2024-03-31
May 1, 2024
8-K
Results of operations (earnings release)
May 1, 2024
10-K
Fiscal year ended 2023-12-31
Feb 9, 2024
8-K
Results of operations (earnings release)
Feb 7, 2024
8-K
Other events
Nov 13, 2023
8-K
Other events
Nov 9, 2023
10-Q
Quarter ended 2023-09-30
Oct 31, 2023